Rank #1310LXRX

Lexicon Pharmaceuticals, Inc.

$1.52

15.15% (Daily)

Market Cap

$635.16M

Revenue

$70.86M

Rank by MCap

#1310

Sector

Healthcare

Industry

Biotechnology

CEO

Dr. Michael S. Exton Ph.D.

Headquarters

The Woodlands, TX

Employees

103

About Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company offers Sotagliflozin, an orally-delivered small molecule drug to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits in adults with heart failure or type 2 diabetes mellitus, chronic kidney disease or CKD, and other cardiovascular risk factors. ...